» Articles » PMID: 38781018

Endothelial to Mesenchymal Notch Signaling Regulates Skeletal Repair

Overview
Journal JCI Insight
Date 2024 May 23
PMID 38781018
Authors
Affiliations
Soon will be listed here.
Abstract

We present a transcriptomic analysis that provides a better understanding of regulatory mechanisms within the healthy and injured periosteum. The focus of this work is on characterizing early events controlling bone healing during formation of periosteal callus on day 3 after fracture. Building on our previous findings showing that induced Notch1 signaling in osteoprogenitors leads to better healing, we compared samples in which the Notch 1 intracellular domain is overexpressed by periosteal stem/progenitor cells, with control intact and fractured periosteum. Molecular mechanisms and changes in skeletal stem/progenitor cells (SSPCs) and other cell populations within the callus, including hematopoietic lineages, were determined. Notably, Notch ligands were differentially expressed in endothelial and mesenchymal populations, with Dll4 restricted to endothelial cells, whereas Jag1 was expressed by mesenchymal populations. Targeted deletion of Dll4 in endothelial cells using Cdh5CreER resulted in negative effects on early fracture healing, while deletion in SSPCs using α-smooth muscle actin-CreER did not impact bone healing. Translating these observations into a clinically relevant model of bone healing revealed the beneficial effects of delivering Notch ligands alongside the osteogenic inducer, BMP2. These findings provide insights into the regulatory mechanisms within the healthy and injured periosteum, paving the way for novel translational approaches to bone healing.

Citing Articles

CD47 is required for mesenchymal progenitor proliferation and fracture repair.

Zondervan R, Capobianco C, Jenkins D, Reicha J, Fredrick L, Lam C Bone Res. 2025; 13(1):29.

PMID: 40025005 PMC: 11873311. DOI: 10.1038/s41413-025-00409-0.


Endothelial-mesenchymal crosstalk drives osteogenic differentiation of human osteoblasts through Notch signaling.

Perepletchikova D, Daria P, Kuchur P, Polina K, Basovich L, Liubov B Cell Commun Signal. 2025; 23(1):100.

PMID: 39972367 PMC: 11841332. DOI: 10.1186/s12964-025-02096-0.


Adipose-derived stem cell exosomal miR-21-5p enhances angiogenesis in endothelial progenitor cells to promote bone repair via the NOTCH1/DLL4/VEGFA signaling pathway.

Cao L, Sun K, Zeng R, Yang H J Transl Med. 2024; 22(1):1009.

PMID: 39516839 PMC: 11549876. DOI: 10.1186/s12967-024-05806-3.


HIF1 activation safeguards cortical bone formation against impaired oxidative phosphorylation.

Khan M, Sabini E, Beigel K, Lanzolla G, Laslow B, Wang D JCI Insight. 2024; 9(18).

PMID: 39088272 PMC: 11457864. DOI: 10.1172/jci.insight.182330.

References
1.
Matthews B, Novak S, Sbrana F, Funnell J, Cao Y, Buckels E . Heterogeneity of murine periosteum progenitors involved in fracture healing. Elife. 2021; 10. PMC: 7906599. DOI: 10.7554/eLife.58534. View

2.
Zanotti S, Canalis E . Notch Signaling and the Skeleton. Endocr Rev. 2016; 37(3):223-53. PMC: 4890266. DOI: 10.1210/er.2016-1002. View

3.
Klose R, Berger C, Moll I, Adam M, Schwarz F, Mohr K . Soluble Notch ligand and receptor peptides act antagonistically during angiogenesis. Cardiovasc Res. 2015; 107(1):153-63. DOI: 10.1093/cvr/cvv151. View

4.
Bailis W, Yashiro-Ohtani Y, Fang T, Hatton R, Weaver C, Artis D . Notch simultaneously orchestrates multiple helper T cell programs independently of cytokine signals. Immunity. 2013; 39(1):148-59. PMC: 3762693. DOI: 10.1016/j.immuni.2013.07.006. View

5.
Hilton M, Tu X, Wu X, Bai S, Zhao H, Kobayashi T . Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med. 2008; 14(3):306-14. PMC: 2740725. DOI: 10.1038/nm1716. View